RLAY vs VYM
Relay Therapeutics Inc (RLAY) versus VYM (VYM) — a side-by-side from cached financials, not a winner call.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
VYM (VYM) common stock.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
VYM does not have a complete income-statement cache yet.
RLAY currently screens at market cap $3.39B. VYM currently screens at market cap $0.
Not investment advice. Open the RLAY and VYM stock pages for the full models.
Not investment advice.